Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs ▼ | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| UCB S.A. | 1 | 0 | 0 | 0 | 150,55 € | - | - |
| Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | 453,70 € | 440,93 € | -2,82 % |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | 25,89 € | 35,01 € | 35,21 % |
| Novavax Inc. | 4 | 1 | 0 | 1 | 15,34 € | 22,18 € | 44,55 % |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | 10,59 € | 27,02 € | 155,11 % |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | 54,00 € | 83,92 € | 55,40 % |
| Halozyme Therapeutics Inc. | 20 | 0 | 0 | 0 | 51,62 € | 55,13 € | 6,81 % |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | 8,95 € | - | - |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 2 | 0 | 9,48 € | 27,83 € | 193,64 % |
| Zealand Pharma A/s | 1 | 0 | 1 | 0 | 124,60 € | - | - |
| Codexis Inc. | 6 | 1 | 0 | 0 | 3,36 € | 8,36 € | 148,64 % |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | 110,40 € | - | - |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | 30,60 € | 41,46 € | 35,50 % |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | 43,80 € | 48,75 € | 11,30 % |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | 74,00 € | 83,92 € | 13,41 % |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | 1,36 € | 3,64 € | 167,97 % |
| Ultragenyx Pharmaceutical Inc. | 23 | 1 | 1 | 0 | 41,60 € | 86,28 € | 107,40 % |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | 3,76 € | - | - |
| Affimed N.V. | 12 | 6 | 0 | 0 | 0,55 € | 6,61 € | 1095,57 % |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 125,00 € | 150,00 € | 20,00 % |
| Abeona Therapeutics Inc. | 6 | 1 | 2 | 0 | 4,72 € | 19,31 € | 309,10 % |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | 70,50 € | - | - |
| Aclaris Therapeutics Inc | 1 | 0 | 0 | 0 | 1,27 € | 3,00 € | 136,41 % |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | 18,82 € | 20,00 € | 6,30 % |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | 151,00 € | 241,54 € | 59,96 % |